Exova Group Plc (EXO) Price Target Cut to GBX 220 by Analysts at Barclays PLC
A number of other brokerages have also recently weighed in on EXO. Shore Capital reiterated a buy rating on shares of Exova Group Plc in a research note on Thursday, September 22nd. Goldman Sachs Group Inc. decreased their price target on shares of Exova Group Plc from GBX 250 ($3.12) to GBX 240 ($3.00) and set a buy rating for the company in a research note on Friday. Peel Hunt increased their price target on shares of Exova Group Plc from GBX 170 ($2.12) to GBX 210 ($2.62) and gave the stock an add rating in a research note on Wednesday, August 31st. Finally, Credit Suisse Group AG restated an outperform rating and issued a GBX 220 ($2.75) target price on shares of Exova Group Plc in a research note on Thursday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. The company has a consensus rating of Buy and a consensus target price of GBX 223 ($2.79).
Exova Group Plc (LON:EXO) opened at 181.50 on Friday. The firm’s market capitalization is GBX 454.47 million. The company’s 50-day moving average is GBX 199.23 and its 200-day moving average is GBX 192.52. Exova Group Plc has a 52-week low of GBX 123.00 and a 52-week high of GBX 215.00.
The business also recently declared a dividend, which was paid on Wednesday, November 9th. Stockholders of record on Thursday, October 27th were issued a GBX 1.05 ($0.01) dividend. The ex-dividend date was Thursday, October 27th. This represents a dividend yield of 0.53%.
About Exova Group Plc
Exova Group plc is a United Kingdom-based provider of testing and advisory services. The Company is a laboratory-based testing company operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. The Company’s segments include Europe, Americas and Rest of World.
Receive News & Stock Ratings for Exova Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exova Group Plc and related stocks with our FREE daily email newsletter.